Cargando…

The time between vaccination and infection impacts immunity against SARS-CoV-2 variants

As the COVID-19 pandemic continues, long-term immunity against SARS-CoV-2 will be globally important. Official weekly cases have not dropped below 2 million since September of 2020, and continued emergence of novel variants have created a moving target for our immune systems and public health alike....

Descripción completa

Detalles Bibliográficos
Autores principales:	Bates, Timothy A., Leier, Hans C., McBride, Savannah K., Schoen, Devin, Lyski, Zoe L., Lee, David X., Messer, William B., Curlin, Marcel E., Tafesse, Fikadu G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cold Spring Harbor Laboratory 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9844016/ https://www.ncbi.nlm.nih.gov/pubmed/36656773 http://dx.doi.org/10.1101/2023.01.02.23284120

Ejemplares similares

An extended interval between vaccination and infection enhances hybrid immunity against SARS-CoV-2 variants
por: Bates, Timothy A., et al.
Publicado: (2023)

Vaccination before or after SARS-CoV-2 infection leads to robust humoral response and antibodies that effectively neutralize variants
por: Bates, Timothy A., et al.
Publicado: (2022)

Previously infected vaccinees broadly neutralize SARS-CoV-2 variants
por: Leier, Hans C., et al.
Publicado: (2021)

Neutralization of SARS-CoV-2 variants by convalescent and vaccinated serum
por: Bates, Timothy A., et al.
Publicado: (2021)

A potent alpaca-derived nanobody that neutralizes SARS-CoV-2 variants
por: Weinstein, Jules B., et al.
Publicado: (2022)

BNT162b2-induced neutralizing and non-neutralizing antibody functions against SARS-CoV-2 diminish with age
por: Bates, Timothy A., et al.
Publicado: (2022)

Neutralization of SARS-CoV-2 variants by convalescent and BNT162b2 vaccinated serum
por: Bates, Timothy A., et al.
Publicado: (2021)

Cross-reactivity of SARS-CoV structural protein antibodies against SARS-CoV-2
por: Bates, Timothy A., et al.
Publicado: (2021)

Omicron neutralizing antibody response following booster vaccination compared with breakthrough infection
por: Curlin, Marcel E., et al.
Publicado: (2022)

Omicron neutralizing antibody response following booster vaccination compared with breakthrough infection
por: Curlin, Marcel E., et al.
Publicado: (2022)

Cross-reactivity of SARS-CoV structural protein antibodies against SARS-CoV-2
por: Bates, Timothy A., et al.
Publicado: (2020)

BNT162b2 induced neutralizing and non-neutralizing antibody functions against SARSCoV-2 diminish with age
por: Bates, Timothy A., et al.
Publicado: (2022)

SARS-CoV-2 specific memory B-cells from individuals with diverse disease severities recognize SARS-CoV-2 variants of concern.
por: Lyski, Zoe L., et al.
Publicado: (2021)

Lipids and pathogenic flaviviruses: An intimate union
por: Leier, Hans C., et al.
Publicado: (2018)

A global lipid map reveals host dependency factors conserved across SARS-CoV-2 variants
por: Farley, Scotland E., et al.
Publicado: (2022)

Diverging maternal and infant cord antibody functions from SARS-CoV-2 infection and vaccination in pregnancy
por: Adhikari, Emily H., et al.
Publicado: (2023)

Approaches to Interrogating the Human Memory B-Cell and Memory-Derived Antibody Repertoire Following Dengue Virus Infection
por: Lyski, Zoe L., et al.
Publicado: (2019)

A lyophilized colorimetric RT-LAMP test kit for rapid, low-cost, at-home molecular testing of SARS-CoV-2 and other pathogens
por: Song, Xin, et al.
Publicado: (2022)

Establishment of Monoclonal Antibody Standards for Quantitative Serological Diagnosis of SARS-CoV-2 in Low-Incidence Settings
por: Thomas, Archana, et al.
Publicado: (2021)

Cellular and humoral immune response to mRNA COVID-19 vaccination in subjects with chronic lymphocytic leukemia
por: Lyski, Zoe L., et al.
Publicado: (2022)

Sphingomyelin Biosynthesis Is Essential for Phagocytic Signaling during Mycobacterium tuberculosis Host Cell Entry
por: Niekamp, Patrick, et al.
Publicado: (2021)

A global lipid map defines a network essential for Zika virus replication
por: Leier, Hans C., et al.
Publicado: (2020)

A Single Dose of ChAdOx1 nCoV-19 Vaccine Elicits High Antibody Responses in Individuals with Prior SARS-CoV-2 Infection Comparable to That of Two-Dose-Vaccinated, SARS-CoV-2-Infection-Naïve Individuals: A Longitudinal Study in Ethiopian Health Workers
por: Gelanew, Tesfaye, et al.
Publicado: (2022)

Development and validation of an enzyme immunoassay for detection and quantification of SARS-CoV-2 salivary IgA and IgG
por: Costantini, Veronica P., et al.
Publicado: (2021)

Non‐structural protein 1‐specific antibodies directed against Zika virus in humans mediate antibody‐dependent cellular cytotoxicity
por: Sanchez Vargas, Luis A., et al.
Publicado: (2021)

Impacts of rapid mass vaccination against SARS-CoV2 in an early variant of concern hotspot
por: Paetzold, Jörg, et al.
Publicado: (2022)

Potency and breadth of human primary ZIKV immune sera shows that Zika viruses cluster antigenically as a single serotype
por: Nix, Chad D., et al.
Publicado: (2020)

The Squeaky Yeast Gets Greased: The Roles of Host Lipids in the Clearance of Pathogenic Fungi
por: Guzman, Gaelen, et al.
Publicado: (2020)

“Flash & Click”: Multifunctionalized Lipid Derivatives as Tools To Study Viral Infections
por: Schultz, Carsten, et al.
Publicado: (2022)

Ceramide synthase 2 deletion decreases the infectivity of HIV-1
por: Barklis, Eric, et al.
Publicado: (2021)

Antibody cocktail effective against variants of SARS-CoV-2
por: Liang, Kang-Hao, et al.
Publicado: (2021)

Screening for inhibitors against SARS-CoV-2 and its variants
por: Yuan, Weijing, et al.
Publicado: (2022)

Are the new SARS-CoV-2 variants resistant against the vaccine?
por: Abdalla, Mohnad, et al.
Publicado: (2021)

In vitro activity of cysteamine against SARS-CoV-2 variants
por: Thoene, Jess, et al.
Publicado: (2022)

Genetic Variants and Protective Immunity against SARS-CoV-2
por: Rabaan, Ali A., et al.
Publicado: (2022)

High Seroprevalence of Anti-SARS-CoV-2 Antibodies Among Ethiopian Healthcare Workers
por: Gelanew, Tesfaye, et al.
Publicado: (2021)

High seroprevalence of anti-SARS-CoV-2 antibodies among Ethiopian healthcare workers
por: Gelanew, Tesfaye, et al.
Publicado: (2022)

Immunogenicity of Pfizer mRNA COVID-19 vaccination followed by J&J adenovirus COVID-19 vaccination in two CLL patients
por: Lyski, Zoe L., et al.
Publicado: (2021)

Omicron variant of SARS-CoV-2 exhibits an increased resilience to the antiviral type I interferon response
por: Shalamova, Lyudmila, et al.
Publicado: (2022)

Palmitoylation of SARS-CoV S protein is necessary for partitioning into detergent-resistant membranes and cell–cell fusion but not interaction with M protein
por: McBride, Corrin E., et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_14qaed8tmadoponamj3lrsu3g9